U.S. Food and Drug Administration
Protecting and Promoting Your Health
Small Business Assistance
Center for Drug Evaluation and Research
Engaging with the FDA During New Drug Development
Formal Meetings with FDA
|
Question: Is the post-action meeting requested 3 months AFTER an action considered a new Type A meeting?
|
|
Answer:Yes, this was established under PDUFA V. |
USER INSTRUCTIONS:
Click NEXT to continue.
Page 11 of 38
